Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-19 Hansen Gwenn Chief Scientific Officer Grant or award · Restricted Stock Units +51,308 51,308
2022-01-10 Ring Christine General Counsel Option exercise +1,200 $1.86 $2K 2,486
2022-01-10 Ring Christine General Counsel Sale −1,200 $27.14 $33K 1,286
2022-01-10 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −1,200 100,066
2022-01-03 Hansen Gwenn Chief Scientific Officer Option exercise +400 $7.26 $3K 14,597
2022-01-03 Hansen Gwenn Chief Scientific Officer Option exercise +1,428 $9.57 $14K 16,025
2022-01-03 Hansen Gwenn Chief Scientific Officer Sale −1,828 $28.96 $53K 14,197
2022-01-03 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −400 67,466
2022-01-03 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −1,428 81,905
2021-12-10 Ring Christine General Counsel Option exercise +1,200 $1.86 $2K 2,486
2021-12-10 Ring Christine General Counsel Sale −1,200 $29.04 $35K 1,286
2021-12-10 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −1,200 101,266
2021-12-01 Hansen Gwenn Chief Scientific Officer Option exercise +400 $7.26 $3K 14,597
2021-12-01 Hansen Gwenn Chief Scientific Officer Sale −400 $29.13 $12K 14,197
2021-12-01 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −400 67,866
2021-11-10 Ring Christine General Counsel Option exercise +1,200 $1.86 $2K 2,486
2021-11-10 Ring Christine General Counsel Sale −1,200 $32.38 $39K 1,286
2021-11-10 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −1,200 102,466
2021-11-01 Hansen Gwenn Chief Scientific Officer Option exercise +400 $7.26 $3K 14,597
2021-11-01 Hansen Gwenn Chief Scientific Officer Sale −400 $33.24 $13K 14,197

Page 30 of 32 · 632 trades